Navigation Links
Apex Fights Back Against ResMed's Patent Litigation
Date:8/20/2013

BREA, Calif., Aug. 20, 2013 /PRNewswire/ -- On August 20, 2013, Apex Medical Corp. announced at a press conference its challenges to six of the seven patents that were involved in an investigation by the U.S. International Trade Commission (ITC), which was terminated by the ITC on August 9, as well as introduction of products related to obstructive sleep apnea (OSA) syndrome.

Apex has brought invalidity challenges before the U.S. Patent and Trademark Office (USPTO) against six of the seven patents that ResMed asserted in the patent litigation. Apex challenges these patents in accordance with the new procedure under the Leahy-Smith America Invents Act (AIA), which allows reexamination of issued patents if substantial invalidity evidence is provided.

At the press conference, Apex also introduced new CPAP machines and masks for sleep-disorder breathing treatment. The new CPAP machines and masks are more innovative in terms of the clinical effectiveness, user friendliness, and design. The light, compact new iCH has a stylish design that integrates the water chamber to the body, which prevents water leakage. The new mask provides more effective exhaustion of CO2 and quieter user experience.

Apex's President, Mr. Daniel Lee, said to the press: "We proudly introduce our new CPAP machines and masks to the industry. In the R&D process we considered valuable feedback from our users all over the world in order to make Apex the best choice for dealers and consumers. The new iCH and masks are scheduled to be offered to the market in September following submission of expert analysis to the ITC." "We believe that the CPAP machines and masks will provide unparalleled user experience through their quiet and contemporary design," Mr. Lee added.

About Apex

Operating under principles of integrity, professionalism, and innovation, Apex markets a global brand for breathing treatment systems and possesses exceptional ability in product development, manufacturing, and marketing. Our excellent team of professionals specializing in medicine, engineering, materials, organization, and clinical trials has been devoted to developing its own technology and intellectual property. We aim to provide consumers worldwide access to top-quality products and to become the leading company in the market for breathing treatment products.

Contact Information:

PJ Hsueh
General Manager
+1-714-671-3818
PJ.Hsueh@apexmedical.com.tw  
Apex Medical USA


'/>"/>
SOURCE Apex Medical Corp.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Cepheid Launches Mobile Community for Ride Against TB Campaign to Benefit the American Lung Association
2. West Virginia Retailers Association Highlights Success Of NPLEx In Battle Against Meth Labs
3. Lakewood-Amedex Announces Its Novel Bisphosphocin Class Of Antimicrobials Are Active Against NDM-1 Positive Bacterial Strains
4. Third Circuit Rules in Mylans Favor Regarding Paroxetine Hydrochloride Extended-Release Tablets, Sending Mylans Breach of Contract Claim Against GSK to Trial
5. MELA Sciences, Inc., A Leader In The Fight Against Melanoma, Hosts Symposium At 8th World Congress Of Melanoma
6. ResMed Succeeds in Patent Fight Against APEX
7. UK Ministers to Block Law against Headshops
8. CHPA Applauds Pennsylvanias Adoption of Real-Time, Stop-Sale Technology, An Effective Tool in the Fight Against Methamphetamine
9. Breckenridge Announces Dismissal of Various Lawsuits Against Macoven Pharmaceuticals in Return for Macovens Discontinuance of Certain Products
10. Allstate Insurance Company Files $6.6 Million Medical Fraud Lawsuit Against 47 Durable Medical Supply Entities and their Respective Individual Owners
11. Moscamed Launches Urban Scale Project Using Oxitec GM Mosquitoes in Battle Against Dengue
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... -- Research and Markets has announced the addition of ... report to their offering. ... The report provides separate comprehensive analytics for the US, Canada ... Asia-Pacific , Latin America , and ... 2015 through 2022. Also, a six-year historic analysis is provided for these ...
(Date:3/24/2017)... , March 24, 2017  Eli Lilly ... announced plans to invest $850 million in its ... facilities across its U.S. enterprise, including research laboratories, ... investments are being driven by demand for Lilly ... potential medicines in development targeting cancer, pain, diabetes ...
(Date:3/24/2017)... , March 23, 2017  Mirabilis Medical, ... advanced medical technology for non-invasive surgery, announced today ... System for treatment of uterine fibroids throughout the ... had received approval from the US Food and ... the Mirabilis System in the United States.  The ...
Breaking Medicine Technology:
(Date:3/24/2017)... ... March 24, 2017 , ... Gastro Health ... partnership to prep patients for colonoscopy at the HyGIeaCare® Center that is to ... Miami, FL. , The HyGIeaCare® Prep, cleared by the U.S. Food ...
(Date:3/24/2017)... ... 2017 , ... “Finding Christ Through Social Media: Year One ... the writer’s path toward true communion with God. “Finding Christ Through Social Media: ... creation of published author Lea Michelle Johnson, a follower of Christ, wife and ...
(Date:3/24/2017)... ... March 24, 2017 , ... “The Communion of ... people of God in congregations across the United States. “The Communion of ... in 1964 who has served congregations in seven states throughout his long career ...
(Date:3/23/2017)... ... 23, 2017 , ... A recent report from the National Council on Teacher ... NCTQ report suggests, based on a review of GPA and SAT/ACT requirements at 221 ... the U.S. It argues that this higher bar should be set by states, by ...
(Date:3/23/2017)... ... March 23, 2017 , ... Texas Physical Therapy Specialists (TexPTS) ... Road in Building 2. The clinic is the group’s second in New Braunfels and ... the company’s second New Braunfels location brings things full circle for the group, “It’s ...
Breaking Medicine News(10 mins):